News & Updates

In patients with left-sided malignant colorectal obstruction (LMCO), deferring surgery for >4 weeks after placement of self-expanding metallic stent (SEMS) appears to yield better short-term clinical outcomes, according to a recent study.

Fruquintinib, a highly selective and potent oral tyrosine kinase inhibitor of VEGFR*-1, -2, and -3, significantly improves overall survival (OS) in heavily pretreated patients with metastatic colorectal cancer (mCRC), according to the FRESCO-2** trial presented at ESMO 2022.

Currently in vogue, intermittent fasting (IF) – which switches between periods of eating and fasting – may not be as beneficial as many have thought.

COVID-19 reinfection doubles the risk of death and triples the risk of hospitalization, with post-acute sequelae in the pulmonary and extra-pulmonary organ systems, in a new study.

Treatment with HTD1801, an ionic salt of berberine and ursodeoxycholic acid with pleiotropic mechanisms of action, appears to substantially improve outcomes in patients with primary sclerosing cholangitis (PSC), according to a study.